Researchers in London used a genetically modified form of herpes simplex to attack tumors in cancer patients’ bodies. The treatment has seemingly already saved the life of at least one patient, Krzysztof Wojkowski, from West London. The virus injections, known as RP2, are administered directly into the tumor. The immune system is also activated to help finish the job, where the cancer cells burst. The researchers presented these findings at the ESMO Congress medical conference in Paris last week.Read Long Article
